Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Seeks Agreement with U.K. Government to Raise Prices for Medicines: Report
2
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
3
Roundup: FDA Approves Awiqli for Treatment of Type 2 Diabetes in Adults, FDA Approves Kresladi for Severe Leukocyte in Pediatric Patients
4
Trump Administration Pauses Search for New Head of CDC: Report
5